B
BDR Pharmaceuticals
Focuses on development in 4 specialized therapeutic segments, viz. oncology, critical care, gynecology and neurology
About BDR Pharmaceuticals
BDR Pharmaceuticals International Pvt. Ltd. is a leading player in the pharmaceutical industry, specializing in the development and marketing of generic formulations and niche Active Pharmaceutical Ingredients (APIs). The company operates state-of-the-art manufacturing facilities and DSIR-approved R&D centers, ensuring compliance with global cGMP standards for quality. BDR Pharma focuses on technological advancements in drug delivery systems, including the development of sustained and modified release pellets and water-soluble complexes for oncology products to enhance bioavailability. The company serves a diverse client base, including healthcare providers and pharmaceutical companies, primarily in critical and life-threatening healthcare segments. BDR Pharma's business model revolves around contract manufacturing and the introduction of new molecules using innovative production techniques. Revenue is generated through the sale of high-quality pharmaceutical products and contract manufacturing services.
Source: Dealroom company dataAt a glance
- Founded
- 2003
- Headquarters
- Mumbai, India
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Multiples Alternate Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BDR Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BDR Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.